Serum ceruloplasmin levels in preeclampsia: a meta-analysis

References

• Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376:631–644.
   PubMed Web of Science ®Google Scholar
• Phipps E, Prasanna D, Brima W, et al. Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol. 2016;11:1102–1113.
   PubMed Web of Science ®Google Scholar
• Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol. 2006;45:189–200.
   PubMedGoogle Scholar
• Kimura C, Watanabe K, Iwasaki A, et al. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction. J Matern Fetal Neonatal Med. 2013;26:491–496.
   PubMed Web of Science ®Google Scholar
• Gupta S, Aziz N, Sekhon L, et al. Lipid peroxidation and antioxidant status in preeclampsia. A systematic review. Obstet Gynecol Surv. 2009;64:750–759.
   PubMed Web of Science ®Google Scholar
• Cohen JM, Beddaoui M, Kramer MS, et al. Maternal antioxidant levels in pregnancy and risk of preeclampsia and small for gestational age birth: a systematic review and meta-analysis. PLoS One. 2015;10:e0135192.
   PubMed Web of Science ®Google Scholar
• Kennedy DJ, Fan Y, Wu Y, et al. Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD. Clin J Am Soc Nephrol. 2014;9:462–467.
   PubMed Web of Science ®Google Scholar
• GAY, Sahin E, Semiz E, et al. Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease? Can J Cardiol. 2008;24:209–212.
   PubMed Web of Science ®Google Scholar
• Ziakas A, Gavrilidis S, Souliou E, et al. Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina. Angiology. 2009;60:50–59.
   PubMed Web of Science ®Google Scholar
• Hammadah M, Fan Y, Wu Y, et al. Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure. J Card Fail. 2014;20:946–952.
   PubMed Web of Science ®Google Scholar
• Fan Y, Kang Y, Zhang M. A meta-analysis of copper level and risk of preeclampsia: evidence from 12 publications. Biosci Rep. 2016;36:e00370.
   PubMed Web of Science ®Google Scholar
• Guller S, Buhimschi CS, Ma YY, et al. Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia. Lab Invest. 2008;88:1057–1067.
   PubMed Web of Science ®Google Scholar
• Souza JP, Pileggi C, Cecatti JG. Assessment of funnel plot asymmetry and publication bias in reproductive health meta-analyses: an analytic survey. Reprod Health. 2007;4:3.
   PubMedGoogle Scholar
• Nikolic A, Cabarkapa V, Novakov Mikic A, et al. Ceruloplasmin and antioxidative enzymes in pre-eclampsia. J Matern Fetal Neonatal Med. 2016;29:2987–2993.
   PubMed Web of Science ®Google Scholar
• Mistry HD, Gill CA, Kurlak LO, et al. Association between maternal micronutrient status, oxidative stress, and common genetic variants in antioxidant enzymes at 15 weeks gestation in nulliparous women who subsequently develop preeclampsia. Free Radic Biol Med. 2015;78:147–155.
   PubMed Web of Science ®Google Scholar
• Hameed RM, Wasah GA. Total iron binding capacity (TIBC), free iron, ceruloplasmin, transferrin and ferritin concentration, in pregnant women with pre-eclampsia. Al-Kufa. J Biol. 2013;5.
   Google Scholar
• Mihu D, Sabău L, Costin N, et al. Implications of maternal systemic oxidative stress in normal pregnancy and in pregnancy complicated by preeclampsia. J Matern Fetal Neonatal Med. 2012;25:944–951.
   PubMed Web of Science ®Google Scholar
• Monia MM, Fethi BA, Wafa LB, et al. Status of zinc and copper in pregnant women and their changes during preeclampsia. Ann Biol Clin (Paris). 2012;70:423–429.
   PubMed Web of Science ®Google Scholar
• Vanitha Gowda MN, Aroor AR, Krisna L. Studies on oxidative stress in preeclampsia. Biomed Res. 2010;21:71–79.
   Google Scholar
• Kristensen K, Wide-Swensson D, Lindstrom V, et al. Serum amyloid A protein and C-reactive protein in normal pregnancy and preeclampsia. Gynecol Obstet Invest. 2009;67:275–280.
   PubMed Web of Science ®Google Scholar
• Engin-Ustün Y, Ustün Y, Kamaci M, et al. Maternal serum ceruloplasmin in preeclampsia. Int J Gynaecol Obstet. 2005;89:51–52.
   PubMed Web of Science ®Google Scholar
• Vitoratos N, Salamalekis E, Dalamaga N, et al. Defective antioxidant mechanisms via changes in serum ceruloplasmin and total iron binding capacity of serum in women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1999;84:63–67.
   PubMed Web of Science ®Google Scholar
• Wisdom SJ, Wilson R, McKillop JH, et al. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol. 1991;165:1701–1704.
   PubMed Web of Science ®Google Scholar
• Griffin JF. Pregnancy-associated plasma protein levels at term in normal pregnancy, preeclampsia and essential hypertension. Aust NZ J Obstet Gynaecol. 1983;23:11–14.
   PubMed Web of Science ®Google Scholar
• Shakour-Shahabi L, Abbasali-Zadeh S, Rashtchi-Zadeh N. Serum level and antioxidant activity of ceruloplasmin in preeclampsia. Pak J Biol Sci. 2010;13:621–627.
   PubMedGoogle Scholar
• Serdar Z, Gür E, Develioğlu O. Serum iron and copper status and oxidative stress in severe and mild preeclampsia. Cell Biochem Funct. 2006;24:209–215.
   PubMed Web of Science ®Google Scholar
• Aksoy H, Taysi S, Altinkaynak K, et al. Antioxidant potential and transferrin, ceruloplasmin, and lipid peroxidation levels in women with preeclampsia. J Investig Med. 2003;51:284–287.
   PubMed Web of Science ®Google Scholar
• Fattah MM, Ibrahim FK, Ramadan MA, et al. Ceruloplasmin and copper level in maternal and cord blood and in the placenta in normal pregnancy and in pre-eclampsia. Acta Obstet Gynecol Scand. 1976;55:383–385.
   PubMed Web of Science ®Google Scholar
• Dey M, Arora D, Narayan N, et al. Serum cholesterol and ceruloplasmin levels in second trimester can predict development of pre-eclampsia. North Am J Med Sci. 2013;5:41–46.
   PubMedGoogle Scholar
• Farzin L, Sajadi F. Comparison of serum trace element levels in patients with or without pre-eclampsia. J Res Med Sci. 2012;17:938–941.
   PubMed Web of Science ®Google Scholar
• Orhan HG, Ozgüneş H, Beksaç MS. Correlation between plasma malondialdehyde and ceruloplasmin activity values in preeclamptic pregnancies. Clin Biochem. 2001;34:505–506.
   PubMed Web of Science ®Google Scholar
• Khetsuriani T, Sanikidze T, Khugashvili R. Alterations of oxidative metabolism at the pregnancy attended with pre-eclampsia. Ann Biomed Res Educ. 2004;4:34–36.
   Google Scholar
• Mikaelyan NP, Knyazev YA, Mikaelyan AV, et al. Lipid–protein complexes in erythrocyte membrane in late gestosis. Bull Exp Biol Med. 2001;132:678–681.
   PubMed Web of Science ®Google Scholar
• Hubel CA, Kozlov AV, Kagan VE, et al. Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: implications for oxidative stress. Am J Obstet Gynecol. 1996;175:692–700.
   PubMed Web of Science ®Google Scholar
• Linder MC. Ceruloplasmin and other copper binding components of blood plasma and their functions: an update. Metallomics. 2016;8:887–905.
   PubMed Web of Science ®Google Scholar
• Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, et al. Novel biomarkers of heart failure. Adv Clin Chem. 2017;79:93–152.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Brown MA, Zeeman GG, et al. The definition of severe and early-onset preeclampsia. Statements from the International society for the study of hypertension in pregnancy (ISSHP). Pregnancy Hypertens. 2013;3:44–47.
   PubMed Web of Science ®Google Scholar